Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Hair growth phase in mice weakens certain immune responses.

ILC1-like cells can independently cause alopecia areata.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

More research is needed to understand and treat cicatricial alopecias.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata is an autoimmune hair loss condition linked to genetic factors.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Inflammation damages sweat ducts, causing sweat gland injury.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Permanent hair dye may cause total hair loss.

Hair loss treatment caused more hair loss in a man.